SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:oru-81776"
 

Search: onr:"swepub:oai:DiVA.org:oru-81776" > Distribution and ch...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Distribution and characteristics of androgen receptor (AR) in breast cancer among women in Addis Ababa, Ethiopia : A cross sectional study

Hadgu, Endale (author)
Department of Biochemistry, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia
Seifu, Daniel (author)
Department of Biochemistry, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia
Tigneh, Wondemagegnhu (author)
Department of Oncology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia
show more...
Bokretsion, Yonas (author)
Department of Pathology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia
Bekele, Abebe (author)
Department of Surgery, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia
Abebe, Markos (author)
Armauer Hansen research Institute (AHRI), Addis Ababa, Ethiopia
Sollie, Thomas (author)
School of Medical Sciences, Örebro University, Örebro, Sweden
Karlsson, Christina, 1968- (author)
Örebro universitet,Institutionen för hälsovetenskaper
Karlsson, Mats G., 1960- (author)
Örebro universitet,Institutionen för medicinska vetenskaper
show less...
 (creator_code:org_t)
2020-05-06
2020
English.
In: PLOS ONE. - : Public Library Science. - 1932-6203. ; 15:5
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Evaluation of the role of androgen receptor (AR) in the biology of breast cancer is an emerging area of research. There are compelling evidences that AR expression may be used to further refine breast cancer molecular subtyping with prognostic and therapeutic implications. Many studies indicated co-expression of AR with the hormonal receptors in breast cancer has a favorable prognosis. AR is also investigated by many researchers as a potential therapeutic target in treatment of breast cancer. Studies on the frequency and distribution of AR in breast cancer among Africans is barely available. Given the heightened interest to understand its role in breast cancer, we determined AR expression and assessed its association with clinicopathological parameters among Ethiopian women. In this study, 112 newly diagnosed patient with invasive breast cancer at Tikur Anbessa Specialized Hospital were enrolled. Immunohistochemical assessment of AR, ER, PR, Ki67 and HER2 were performed using tissue microarrays (TMA) constructed from their primary tumor block. Out of the 112 participants, 91 (81%) were positive for AR expression and the remaining 21 participants (19%) were negative for AR expression. Expression of AR in ER+, HER2+ and TNBC cases were 93%, 83% and 48% respectively. Our study reveals AR is expressed in a significant number of breast cancers patients and this may indicate that breast cancers cases in Ethiopia have favorable prognosis and could benefit from progresses in AR targeted treatments. Since AR expression has important consequences on the prognosis and treatment of breast cancer, further studies with an increased number of participants is necessary to confirm our reports.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • PLOS ONE (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view